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Abstract
Stanniocalcin-1 (STC-1) is a multi-functional glycosylated peptide present in the 
plasma of healthy women postpartum and increased further in pregnancies compli-
cated by preeclampsia. Although the STC-1 gene is expressed by the placenta what 
regulates its secretion and from which cells at the feto-maternal interface is unknown. 
Here, we demonstrate for the first time that the syncytiotrophoblast and cytotropho-
blast are a major site of STC-1 protein expression in first trimester placental tis-
sue. Further, in response to low oxygen, first trimester chorionic villous tissue from 
pregnancies at increased risk of developing preeclampsia secreted significantly more 
STC-1 than normal tissue under the same conditions. Using the human trophoblast 
cell line BeWo we have shown that low oxygen increased the secretion of STC-1 but 
it required co-stimulation with the Adenosine-3', 5'-cyclic monophosphate (cAMP) 
analogue, 8-Bromo adenosine-3', 5'-cyclic monophosphate cAMP (8 Br-cAMP) 
to reach significance. Inhibition of Hypoxia inducible factor 2α (HIF-2α) and the 
Phosphatidylinositol-3 kinase (PI3-Kinase)/AKT/Serum and glucocorticoid-induced 
kinase-1(SGK-1) pathway resulted in significant inhibition of STC-1 secretion. As 
both low oxygen and cAMP are known to play a central role in placental function, 
their regulation of STC-1 points to a potentially important role in the maintenance 
of a normal healthy pregnancy and we would hypothesize that it may act to protect 
against prolonged placental hypoxia seen in preeclampsia.
K E Y W O R D S
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1 |  INTRODUCTION
Stanniocalcin is a secreted glycoprotein first identified in 
bony fish where it acts to regulate calcium and phosphate 
homeostasis.1 Although the mammalian homologue stan-
niocalcin-1 (STC-1) may serve a similar function, a wider 
expression in both normal and pathological tissue would 
suggest other roles. Support for this in mammals comes 
from studies indicating different sub-cellular locations and 
the expression of different molecular forms.2 STC-1 has 
been implicated in a spectrum of biological processes in-
cluding cell migration, apoptosis, and oxidative phosphor-
ylation. It has anti-inflammatory properties3 and acts as a 
calcium channel blocker in the heart.4-7 STC-1 is present in 
the serum of healthy pregnant but not non-pregnant women 
and is further elevated in pregnancies complicated by pre-
eclampsia.8 Although the expression of the gene is detected 
in placental tissue and peaks mid-gestation, the cellular ori-
gin was not reported.8 Collectively these results suggest that 
STC-1 not only has a role in maintaining a healthy preg-
nancy but may also play a part in the pathology of common 
pregnancy complications. However, whether it is playing 
a protective or pathological role has not been established.
One possible role for STC-1 is inhibiting the activity 
of pregnancy-associated plasma protein-A (PAPP-A), a 
proteolytic enzyme that cleaves the inhibitory binding 
protein IGFBP4 and prevents the release of active IGF-
1.9 Circulating maternal IGF-1 acts to both reduce blood 
pressure and stimulate fetal growth.10 It has also been pro-
posed that the effects of STC-1 on the kidney could account 
for the proteinuria and renal failure that can accompany 
preeclampsia.8,11
The aims of this study are threefold: (a) to determine the 
cellular origin of STC-1 in the placenta, (b) to investigate 
how the secretion of STC-1 is regulated, and (c) to determine 
whether first trimester placental tissue from the pregnancies 
at increased risk of developing preeclampsia secrete more 
STC-1 than tissue from low-risk pregnancies.
2 |  MATERIALS AND METHODS
The pharmacological modulators used in this study were ob-
tained from the following manufacturers: 8-Bromo adeno-
sine-3', 5'-cyclic monophosphate ( 8-Br-cAMP), sodium salt 
(Biolog, Germany), protein kinase A (PKA) inhibitor, N-[2-
(p-bromocinnamylamino) ethyl]-5-isoquinoline sulfonamide 
(H89), the Exchange proteins directly activated by cAMP 
(Epac) inhibitor, α-[(2-(3-Chlorophenyl)hydrazinylidene]-
5-(1,1-dimethylethyl)-β-oxo-3-isoxazolepropanenitrile 
(ESI-09), the mTORC 1 and 2 inhibitor, KU0063794 and 
the SGK-1 inhibitor, GSK650394 (Tocris, Abingdon UK), 
PT2385 (AbCam Cambridge UK), the PI3-Kinase inhibitor 
LY294002 (Sellekchem, Absource Diagnostics, Germany), 
AKT inhibitor IV, and Rapamycin (Calbiochem, Watford 
UK), Desferrioximine and NDRG-1 activator, di-2-pyridylk-
etone-4,4,-dimethyl-3-thiosemicarbazone (DP44mT; Sigma 
Gillingham, UK).
2.1 | Doppler ultrasound scanning of first 
trimester uterine arteries
Doppler ultrasound screening of uterine arteries was per-
formed on women undergoing elective surgical termina-
tion of pregnancy at St George's University Hospital, NHS 
Foundation Trust. Inclusion criteria included singleton preg-
nancy, gestational age 8-14  weeks, normal fetal anatomy 
and nuchal translucency thickness, and no known maternal 
medical condition or history of recurrent miscarriage. The 
gestational age was calculated by crown-rump length meas-
urement. Doppler ultrasound was performed by a trained 
sonographer as described previously.12 Following a study of 
10 000 ongoing pregnancies, we have established reference 
ranges of the resistance indices.13 In this study, a high- re-
sistance index (RI) is defined as a pregnancy with bilateral 
uterine artery notches and a mean RI ≥ 95th centile; while a 
normal-RI presents with no uterine artery notches and a mean 
RI < 95th centile. The risk of developing preeclampsia would 
be five times greater in the high-RI group had the pregnancy 
gone to term.
2.2 | Serum samples obtained during the 
third trimester
The patients were recruited from the antenatal clinics and the 
inpatient wards at St George's Hospital. There was no signifi-
cant difference in gestational age between the normotensive 
and pre-eclamptic pregnancies. The diagnosis of preeclampsia 
was made according to the criteria of the International Society 
for the Study of Hypertension in Pregnancy.14 The exclusion 
criteria included major fetal abnormalities and those ending in 
termination, miscarriage, or fetal death before 24 weeks. Data 
on maternal baseline demographics and pregnancy outcomes 
were collected from the hospital maternity records.
2.3 | Immunohistochemistry
Paraffin-embedded placental tissue sections (7  µm) were 
cut and mounted on slides and immersed in xylene, twice 
for 5 mins. The slides were then re-hydrated using a se-
ries of ethanol dilutions from 100% to 70% (v/v) and then 
washed in water for 5 mins. Heat inactivating epitope re-
trieval of STC-1 and cytokeratin-7 (CK-7) was performed 
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using 11 mM tri-sodium citrate, pH 6.0 containing 0.05% 
(v/v) Tween20 or 10 mM Tris buffer pH 10, for the CK-7, 
respectively.
Sections were washed twice with Tris-buffered saline 
pH 10 [(TBS) containing 140 mM NaCl, 2.68 mM KCL, 
16.7 mM Trisma base] and permeabilized using TBS with 
0.2% (v/v) Triton X-100 for 5 min. Sections were washed 
twice and non-specific binding blocked using TBS contain-
ing 1% (w/v) bovine serum albumin (BSA), or 10% (v/v) 
goat serum for one h at room temperature (RT). Sections 
were then incubated with a polyclonal mouse anti-human 
STC-1 antibody (1  µg/mL) (SantaCruz, California, USA) 
or polyclonal mouse anti-human CK-7 antibody [0.621 µg/
ml) (Dako, Glostrup Municipality, Denmark) in TBS con-
taining 1% (v/v) BSA, 0.025% (v/v) Triton X-100 in a hu-
midified chamber overnight. Non-immune IgG of equal 
concentrations from the same species were used as nega-
tive controls.
After an overnight incubation, sections were washed 
with TBS and endogenous peroxidase activity blocked 
with 0.3% (v/v) H202 in TBS. Sections were then incubated 
with Histostain broad spectrum biotin/streptavidin system 
(Invitrogen, Waltham, Massachusetts, USA) following the 
manufacturer's protocol, washed twice in TBS before being 
incubated with 2-Solution (3,3′-diaminobenzidine) DAB kit 
(Roche, Basel, Switzerland). Sections were counter stained 
using Harris Haematoxylin solution and the nuclei blued 
using saturated lithium carbonate solution. Images were taken 
using an Olympus IX70 microscope with an attached XC10 
camera (Olympus, Tokyo, Japan) using CellSens Dimensions 
software (Olympus).
2.4 | Immunocytochemistry
Cells were grown on gelatine-coated glass coverslips under 
the appropriate conditions and then washed twice in PBS 
before fixing with ice–cold methanol for 10 min. The cells 
were then washed twice for 5 min with PBS and incubated 
in PBS containing 0.2% (v/v) Tween 20. After 10 min the 
cells were washed twice for 5 min with PBS and blocked 
with 10% (v/v) goat serum in PBS for 20  mins at room 
temperature. The fixed and blocked cells underwent three 
further 5 min washes in PBS and were incubated with ei-
ther the primary antibody (Anti-STC1 MAB2958 5  µg/
mL; R&D Systems) or isotype-matched immunoglobulin 
control (IgG2βκ, ebioscince) for 1  h at room tempera-
ture. Cells were then washed thrice in PBS for 5 min and 
incubated in the secondary antibody (anti-mouse bioti-
nylated IgG; Vector Labs) for 45 min at room temperature. 
Following, three washes with PBS for 5  min, cells were 
incubated with streptavidin-fluorescein (3.3µg/ml, Vector 
Labs) for 30 min in the dark, at room temperature. All an-
tibodies were diluted in PBS containing 1.5% (v/v) GS and 
0.2% (v/v) Tween-20. Cells were washed thrice with PBS 
and 1-2 drops of DAPI-containing Vectashield (Vector 
Labs) was added. Images were captured using a Nikon 
A1R Confocal Microscope and imported into ImageJ. Each 
image was adjusted using the Brightness and Contrast tool 
using the identical parameters and saved as.PNG.
2.5 | Cell culture
The choriocarcinoma-derived cytotrophoblast cell line 
(BeWo) used in this study were maintained in Dulbecco's 
Modified Eagle's Medium (with 4500  mg/L glucose, so-
dium pyruvate and sodium bicarbonate, Sigma) and Ham's 
F12 medium (1:1) supplemented with 10% (v/v) Fetal 
Calf Serum (FCS), penicillin (100  IU/mL), streptomycin 
(100 µg/mL), and l-glutamine (2 mmol/L).
2.6 | Stimulating cells for enzyme linked 
immunosorbent assay analysis
BeWo cells were seeded at a density of 4-5 × 105 cells per 
well of a 6 well plate in 1.5 mL of the DMEM/HAM’s F-12 
containing 10% (v/v) FCS. The cells were incubated over-
night to allow them to settle and then incubated according to 
the experiments with 100 μM 8Br-cAMP, pharmacological 
inhibitors (GSK650394 at both 100 and 10 μM, LY294002 
at 50  μM and 10  μM, AKT inhibitor IV at 2.5  μM, 5  μM 
KU0063794 at 1  μM, Rapamycin at 10  ng/mL) and also 
stimulators (DP44mT at 25 and 10  μM). To assess the ef-
fect of reduced oxygen, cells were placed inside sealed blood 
bags (Baldwin Medical Supplies, Knoxville, VIC, Australia) 
flushed with 1% oxygen (O2) with 5% CO2 in N2 at 37°C as 
previously described.15 Otherwise cells were incubated at 5% 
CO2 in air at 37°C in a humidified incubator. All the cells 
were incubated for 48 hours at 37°C.
2.7 | Determination of STC-1 in the 
culture medium
After incubation, the cell culture medium was collected, cen-
trifuged at 14 000 g for 5 min and the resulting supernatant 
separated from the pellet. The volume of the supernatant was 
determined. STC-1 in the culture supernatant was determined 
by enzyme-linked immunosorbent assay (ELISA) as per the 
manufacturer's instructions (DuoSet R&D Systems). The 
cells were washed once with PBS and lysed, the protein con-
centration was determined using the Bradford protein assay. 
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The amount STC-1 produced was then expressed per mg of 
total cellular protein.
2.8 | Stimulating cells for western 
blot analysis
BeWo cells were seeded at a density of 6 × 106 cells per 
10 cm dish in culture media and left to adhere overnight. 
The cells were then incubated with the appropriate inhibi-
tor for 20 min before the addition of 8Br-cAMP (100 μM). 
Cells were either incubated at 21% O2, or 1% O2, in 5% 
CO2 and air. All cells were incubated for up to 48  h at 
37°C.
2.9 | Western blot analysis for 
cells and tissue
After incubation the cells were lysed in up to 200 μL of 
RIPA buffer containing 100 mM sodium orthovanadate, 
17 mg/mL aprotinin, phosphoSTOP (Roche) and 10 mg/
mL phenylmethylsulonylfluoride), sonicated, and cen-
trifuged at 14 000 g for 5 min and the supernatant col-
lected. Placental tissue (5-10  mg) was homogenized in 
1 mL of RIPA buffer using a FastPrep-24 homogeniza-
tion tube containing Lysis Matrix D. Protein concentra-
tions were determined using the Bradford protein assay. 
Approximately 30-50 μg of protein per well was resolved 
on a polyacrylamide gel before transfer to Immobilon-FL 
transfer membrane (Millipore, UK). Protein loading and 
transfer efficiency were followed using tubulin. Non-
specific reactivity was then blocked using Tris-buffered 
saline (TBS) with 5% (w/v) low fat milk powder for 1 h 
at room temperature. Blots were probed with the fol-
lowing antibodies: HIF1α (Cell signalling, 1:1000), 
HIF2α (Novis, NB100-122 1:750), and Tubulin (Sigma 
1:10 000) in 5% (w/v) BSA in TBS containing 01% (v/v) 
Tween 20.
The blots were then washed in TBST and incubated 
with goat anti-rabbit IgG conjugated to horseradish perox-
idase (1:10 000; A5420, Sigma, UK) for 1 h at room tem-
perature, and antigen-antibody complexes were detected 
using an enhanced chemiluminescence system (Amersham 
Biosciences UK). Blots were subsequently stripped in buf-
fer containing 62.5  mM Tris pH 6.7, 2% (w/v) SDS and 
100 mM β-mercaptoethanol and probed with a rabbit poly-
clonal antibody to human β-actin or mouse monoclonal an-
tibody to human anti-Tubulin (1:10 000; Ab7291, Abcam 
UK). Where indicated, western blots were scanned and the 
integrated intensity of each band determined using ImageJ 
(http://rsbweb.nih.gov/ij/docs/intro.html). Results were 
expressed as a ratio to loading control within the same 
sample.
2.10 | Transfection of BeWo cells 
with siRNA
Cells were cultured in HAM’s-F12 medium containing 
10% (v/v) FCS without antibiotics for 48 h prior to trans-
fection by Nucleofection (Amaxa Biosystems, Germany). 
Following trypsinzation 2 × 106 cells were resuspended in 
100 µl of cell line solution L with either 300nM of con-
trol siRNA-A (Santa Cruz sc-37007) or targeted si-RNA 
EPAS-1 (Santa Cruz sc-35316) and transfected following 
the manufacturers' instructions using programs X-005 as 
previously detailed.16 Following transfection, cells were 
seeded at approximately 5  ×  105/well of a 6-well plate 
in HAM’s-F12 medium containing 10% (v/v) FCS with-
out antibiotics. After 24 hours, the medium was replaced 
with DMEM/HAM’s F-12 containing 10% (v/v) FCS and 
incubated for 48  h in 1% O2 with and without 100  µM 
8Br-cAMP.
2.11 | Ethics
Subjects involved in this study gave informed written consent 
and the study protocols had either local Wandsworth Ethics 
Committee (ref: 01.96.8, 01.78.5) or the London-Stanmore 
Research Ethics Committee (ref: 12/LO/0810) approval.
2.12 | Statistical analysis
Graph Pad Prism 5.0 (Graph Pad Software Inc, San Diego, 
CA, USA) was used for statistical analysis. At least three 
independent experiments were performed and the results 
expressed as mean + standard error of the mean. Where ap-
propriate a D'Agostino & Pearson normality test was per-
formed followed by a one-way ANOVA with Holm-Sidak's 
multiple comparisons test. A P value of <.05 was considered 
to be statistically significant.
3 |  RESULTS
3.1 | Expression of STC-1 in placental tissue 
and BeWo cells
Immunohistochemical staining of adjacent sections of first 
trimester chorionic tissue demonstrated co-incident ex-
pression of CK-7 and STC-1 in both the syncytium and 
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underlying cytotrophoblasts (Figure 1). Some staining in 
the placental endothelial cells and stromal cells was ob-
served. Immunocytochemical analysis of BeWo cells 
stimulated with 100µM 8Br-cAMP and incubated in 1% O2 
for 48 h indicated largely cytoplasmic staining for STC-1 
(Figure 1).
3.2 | Serum STC-1 in normal 
pregnancies and pregnancies complicated by 
preeclampsia
The circulating serum concentration of STC-1 at term in 
healthy pregnant women and women with preeclampsia was 
F I G U R E  1  Histological and cytochemical analysis of first trimester placental tissue sections and BeWo cells grown in culture. Top Left: 
Treated with non-immune IgG negative control stained purple. Top Right: Treated with mouse monoclonal anti-CK-7 antibody, brown highlights 
positive expression of CK-7. Middle Left: Treated with non-immune IgG negative control, Middle Right: Treated with mouse anti-STC-1 antibody, 
brown highlights positive expression STC-1. The data are representative of results from three different patient samples performed on separate 
occasions. BeWo cells were grown 1% O2 and stimulated with 100 µM 8Br-cAMP for 24 h. Bottom Left: Treated with non-immune IgG negative 
control, Bottom Right: Treated with mouse anti-STC-1 antibody (Green) and the nuclei stained with Dapi (Blue)
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determined by ELISA. The concentration of STC-1 in nor-
mal pregnancy was 11.36 ng/mL ± 4.8 SEM (n = 19) and 
63.71  ±  34.5 SEM ng/mL (n  =  12) for those pregnancies 
complicated by preeclampsia, P < .05 (Figure 2A).
3.3 | Secretion of STC-1 by placental tissue
Freshly isolated first trimester placental tissue from nor-
mal-RI and high-RI pregnancies were incubated for 24 h 
at 1% O2. They were then transferred to fresh medium and 
cultured for a further 72 h. There was significantly more 
STC-1 secreted from the tissue from the high-RI pregnan-
cies compared to the normal-RI placental tissue (P < .01; 
n > 12 experiments as determined by ELISA; Figure 2B).
There was no significant difference in the secretion of 
STC-1 between the two groups when tissue was cultured 
at 21% O2.
3.4 | The effect of 8Br-cAMP and low O2 
on the secretion of STC1 by the trophoblast cell 
line BeWo
The membrane permeable cAMP analogue, 8Br-cAMP, pro-
motes formation of syncytial structures and the secretion of 
Human chorionic gonadotrophin (hCG) by BeWo cells.17 
We, therefore, examined the effect of cAMP on the secretion 
of STC-1 in these cells. At 21% O2 the effect of 8Br-cAMP 
on the secretion of STC-1 by BeWo cells did not reach sta-
tistical significance. Culturing cells in 1% O2 in combination 
with 8Br-cAMP lead to an increase in the secretion of STC-1 
compared to 21% O2 that reached significance at 100  µM 
with a ninefold increase (P  <  .001). The highest dose of 
500  µM resulted in a 19 fold increase (P  <  .0001). These 
data indicate that both cAMP and O2 regulated pathways act 
synergistically to stimulate STC-1 secretion in BeWo cells 
(Figure 3A). It was also possible to mimic the effect of re-
ducing the oxygen concentration by treating the cells with 
the iron chelator desferrioximine, which, at 21% O2 lead 
to a threefold increase in the secretion of STC-1 over 8Br-
cAMP alone and a significant increase compared to control 
(P < .05; Figure 3B).
3.5 | Role of O2 regulated pathways in  
STC-1 secretion
Oxygen regulates cellular activity in a number of ways in-
cluding through the increased stabilization of HIF. Western 
blot analysis demonstrated the expression of both HIF-1 and 
2α in BeWo cells cultured for 48 h in 1% O2 (Figure 3C, D). 
To determine which factor was involved in the regulation 
of STC-1 we used a HIF-2α specific antagonist, PT2385.18 
Incubation of BeWo cells with 1 µM PT2385 significantly in-
hibited the secretion of STC-1 in response to 1% O2/100 µM 
8Br-cAMP (Figure 3E). We confirmed the involvement 
of HIF-2α using RNA-mediated interference. Following 
F I G U R E  2  Concentration of STC-1 in serum obtained from pregnancies in the third trimester with known outcomes. A, Serum was obtained 
from normal and preeclamptic pregnancies the third trimester. The concentration of STC-1 was determined by ELISA and the data log-transformed. 
The data shown are expressed as mean ± SEM of n = 19 normal pregnancies and n = 11 preeclamptic pregnancies. Significance was determined 
using an unpaired student t test *P < .05. Secretion of STC-1 by first trimester chorionic tissue from nRI and hRI pregnancies incubated at 1% and 
21% O2. B, First trimester chorionic villous tissue was incubated at either 1% or 21% O2 for 72 h. The medium was then collected and the tissue 
weighed. STC-1 was determined by ELISA and the amount produced was corrected for the weight of tissue. The number of pregnancies in each 
group were nRI 1% (n = 14), hRI 1% (n = 12), nRI 21% (n = 13) hRI 21% (n = 12). The data were tested for normality using the D'Agostino & 
Pearson normality test before analysis using a one-way ANOVA followed by a Holm-Sidak's multiple comparisons test, **P < .01
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transfection with non-targeting control si-RNA there was a 
significant increase in the secretion of STC-1 following the 
culture of BeWo cells 48  h in 1% O2 and 100  µm cAMP. 
However transfection with HIF-2α siRNA inhibited 1% O2 
and 100 µm cAMP stimulated STC-1  secretion completely 
(Figure 3F).
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3.6 | Investigation of cAMP 
dependent pathways
Having established a role for cAMP in the secretion of STC-
1, we investigated downstream targets of cAMP, PKA and 
Epac. BeWo cells were treated with inhibitors of PKA, H-89 
(10 µM), and the inhibitor of Epac, ESI-09 (50 and 100 µM) 
and then stimulated with 1% O2/100 µM 8Br-cAMP and in-
cubated for 48 h. Inhibition of PKA with H89 had a small, 
but significant effect on STC-1 secretion (P  <  .05, n  =  6; 
Figure 4A); however, inhibition of Epac had no effect (data 
not shown).
3.7 | Role of the PI3-Kinase/AKT pathway 
in the secretion of STC-1 by BeWo
There is evidence to suggest that the PI3-Kinase/Akt pathway 
can be activated in response to elevated cAMP.19 To determine 
whether activation of the PI3-Kinase/Akt pathway is involved 
in regulating the secretion of STC-1 by trophoblasts we used 
the pharmacological modulator Ly294002. Ly294002 in-
hibited the secretion of STC-1 in a dose-dependent manner, 
reaching statistical significance at 10 µM (P < .05; Figure 4B). 
Inhibiting the activation of AKT with AKT inhibitor IV also 
significantly inhibited the secretion of STC-1 in response to 
8Br-cAMP/1% O2 to below the levels of 1% O2 alone (P < .01; 
Figure 4C).
3.8 | Role of mammalian target of 
rapamycin in the secretion of STC-1 by BeWo
Mammalian target of rapamycin (mTOR) is associated with 
two complexes, mTOR complex (mTORC)-1 and -2, which 
act as both downstream and upstream of Akt, respectively. To 
assess the role of mTOR in the secretion of STC-1 we used 
two inhibitors; rapamycin (RAP) which targets mTORC1 
and KU-0063794 which inhibits both mTORC1 and 2. Only 
KU-0063794 (KU) had a significant effect on the secretion of 
STC-1 (P < .01; Figure 4D).
3.9 | Role of SGK-1 in the secretion of STC-
1 by BeWo
The above data implicate mTORC2 in the mediation of 
cAMP/1% O2 stimulated STC-1 secretion. Activation of 
mTORC2 results in the activation of not only AKT but also 
a number of other pathways including SGK-1. Inhibition of 
SGK-1 with GSK 650394 significantly reduced the secre-
tion of STC-1 in a dose-dependent manner (10 µM P < .05 
n = 6 experiments, 100 µM P < .01; Figure 4E). Downstream 
targets of SGK-1 include N-Myc Downstream-Regulated 
Gene 1 (NDRG-1) and Glycogen Synthase Kinase-3β 
(GSK-3β). Using western blot analysis, we were able to 
demonstrate an increase in the phosphorylation and there-
fore activation of NDRG-1 in response to cAMP/1% O2. 
However, direct activation NDRG-1 following stimulation 
with Dp44mt had no effect on the secretion of STC-1 by 
BeWo cells (data not shown). Inhibition of HIF-2α with 
PT2385 had no effect on the phosphorylation of NDRG-1 
(data not shown). To explore the possible involvement 
of the GSK-3β in this process, we incubated BeWo cells 
with kenpaullone, a GSK-3β inhibitor which significantly 
(P < .01) enhanced the secretion of STC-1 in response to 
cAMP/1% O2 (Figure 4F).
4 |  DISCUSSION
The placenta is a pregnancy-specific organ that develops 
rapidly throughout gestation. It acts as the crucial interface 
between the fetus and the mother. It has a number of func-
tions but pertinent to this study is its role as a major endo-
crine organ, modulating, and adapting the maternal response 
to pregnancy. We have focused on STC-1, a little studied 
hormone, which in health is only detectable in the circula-
tion during pregnancy and is further elevated in pregnancies 
complicated by preeclampsia.
In the current study, we established that the protein STC-1 
was predominantly expressed in the syncytiotrophoblast and 
cytotrophoblast cells of first trimester placental tissue where 
it is co-localized with the expression of CK-7. Less intense 
expression was also seen in placental endothelial and stromal 
F I G U R E  3  The effect of cAMP and oxygen on production of STC-1 by BeWo cells. A, BeWo cells (3 × 105 per well) were incubated in 
either 1% or 21% oxygen with increasing concentration of 8Bromo-cAMP. The data were expressed as mean + sem, of n = 4 independent expts. B, 
BeWo cells were cultured in 21% O2 and stimulated with 100 µM 8 Bromo-cAMP in the presence and absence of 50 µM DFO (n = 4 independent 
expts). The effect of the low oxygen and cAMP on the expression of HIF-1, and HIF-2α. BeWo cells were cultured in 1% and 21% O2 in presence 
and absence of 100 µM 8 Bromo-cAMP for 48 h and cell lysates were examined by western blot analysis. C, HIF-1α (n = 4 independent expts) and 
D, HIF-2α (n = 7 independent expts) were detected by chemiluminescence, using tubulin as the loading control. The effect of inhibiting HIF-2α 
on the secretion of STC-1 was determined using (E) PT2385, (n = 3 independent expts) or (F) RNA interference, (n = 4 independent expts) in the 
presence and absence of 100 µM 8 Bromo-cAMP. Stimulation in all experiments was for 48 h. The concentration of STC-1 in the medium was 
determined by ELISA. Total cellular protein was determined by Bradford assay. The results are expressed as pg of STC-1/mg of protein. The level 
of significance was determined using either, a Student t test or a one-way ANOVA and a Sidak's multiple comparisons test where appropriate, 
*P < .05, **P < .01, P < .005(**), P < .0005 (***), P < .0001 (****)
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cells. We were further able to demonstrate a significant differ-
ence in the circulating concentration of STC-1 in the women 
with preeclampsia compared to normal pregnancies. These 
results were largely consistent with previously published data 
from plasma collected post-partum.8 In addition, we found 
that the secretion of STC-1 by first trimester chorionic villous 
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explants cultured at 1% O2 was significantly greater in preg-
nancies at increased risk of developing preeclampsia. As the 
syncytium is the likely source of STC-1 found in the maternal 
circulation we examined the possible mechanisms that might 
regulate the secretion of STC-1 using first trimester placental 
tissue and the BeWo trophoblast cell line.
Human chorionic gonadotrophin stimulates the differen-
tiation of syncytiotrophoblast through the elevation of intra-
cellular cAMP.20 We, therefore, determined whether cAMP 
could play a role in regulating STC-1 secretion using the 
membrane permeable phosphodiesterase resistant analogue, 
8Br-cAMP. Although the effect of cAMP in regulating STC-
1 mRNA expression has been studied, the effect is tissue 
specific. In human endometrial stromal cells and rat neu-
roblastoma cells, cAMP stimulates STC-1 expression.21,22 
However, in rat Sertoli and Leydig cells the opposite effect 
was observed.23 It has previously been reported that elevated 
intracellular cAMP-induced cell fusion and differentiation in 
BeWo cells.24 In this study, 8Br-cAMP alone had no effect 
on the secretion of STC-1 by BeWo cells cultured in atmo-
spheric oxygen suggesting that differentiation of BeWo cells 
alone was insufficient for secretion.
In early gestation, the human fetus develops in a relatively 
low oxygen environment. Around the 10th week of preg-
nancy, the delivery of blood to developing placenta changes 
significantly due to the remodeling of the maternal arteries 
and the loss of the trophoblast plugs.25 In pregnancies that 
later develop preeclampsia and/or fetal growth restriction, 
this remodeling fails to occur adequately resulting in placen-
tal under-perfusion and intermittent hypoxia. We, therefore, 
hypothesized that one possible stimulus for the increased 
placental expression and secretion of STC-1 seen in pre-ec-
lamptic pregnancies could be low oxygen. In support of this, 
low oxygen is associated with increased STC-1 gene expres-
sion in a number of pathological situations including cerebral 
ischemia26 and carcinogenesis27-29 and heart failure.5 Using 
a human tumor cell line, both low oxygen and the chemical 
induction of hypoxia, using either desferoxamine or cobalt 
chloride, also increased STC-1 gene expression.30 Culturing 
BeWo cells in 1% O2 did not increase the secretion of STC-
1. We, therefore, examined whether low oxygen in combina-
tion with increased intracellular cAMP could act to stimulate 
STC-1 secretion and found that there was a dose-dependent 
increase in the secretion of STC-1 in response to 8Br-cAMP 
when cultured in low O2 which reached statistical significance 
at 100 µM 8Br-cAMP. There are at least two intracellular tar-
gets for cAMP in trophoblasts, PKA and Epac. Using inhibi-
tors and activators of these targets, we were able to establish 
that the majority of the stimulus for the secretion of STC-1 by 
BeWo cells was mediated by PKA which was in accord with 
earlier findings in the ovary.31
Oxygen-responsive genes are regulated by members of the 
HIF family of transcription factors. The best-studied isoforms 
are HIF-1α and HIF-2α which share a number of structural 
and functional similarities but differ in expression patterns, 
target genes, and regulatory mechanisms. In low O2, HIF-1α 
and HIF-2α dimerize with HIF-1β forming HIF-1 and HIF-
2, respectively. They then translocate to the nucleus where 
they regulate target gene expression by binding to and acti-
vating a hypoxia response element (HRE). Both HIF-1α and 
HIF-2α proteins are expressed in the human placenta. HIF-1α 
is widely distributed, whereas the expression of HIF-2α is 
restricted largely to the trophoblasts.32,33 A HRE has been 
identified in the promotor of STC-134 and using the HIF-2α 
specific inhibitor PT2385,18 which antagonizes the binding 
of HIF-2α to HIF-1β, we were able to demonstrate that the 
secretion of STC-1 by BeWo cells was HIF-2α mediated. To 
investigate the effect of cAMP on the expression of HIF-2α, 
we used western blot analysis. As predicted, cells grown in 
low O2 expressed HIF-2α and stimulation of cells with 8Br-
cAMP led to a significant increase in expression. PT2385 is 
a selective and potent small-molecule inhibitor of HIF-2α 
identified by a structure-based design approach. It alloster-
ically binds to HIF-2α and blocks heterodimerization with 
HIF-1β.18 Crystallographic analysis of this interaction reveals 
no such binding of PT2385 to HIF-1α. Although this does not 
exclude off-target effects in the current study, it does suggest 
the effects demonstrated are not mediated through the inhi-
bition of HIF-1α. The importance of HIF-2α in regulating 
the secretion of STC-1 was confirmed using validated RNA-
interference techniques targeting the expression of HIF-2α.
Using pharmacological inhibitors and activators, we ex-
amined the interaction between HIF-2α and 8Br-cAMP fur-
ther and have shown that inhibiting PI3-kinase/Akt pathway 
with Ly294002, and Akt-inhibitor IV in BeWo cells led to 
significant inhibition of cAMP/1%O2 induced STC-1 secre-
tion. A similar interaction between the cAMP/PKA and PI3-
Kinase/AKT pathway has been shown in endothelial cells 
where a cAMP-mediated inhibition of Rho-kinase led to an 
increase in PI3-Kinase activation.35,36
F I G U R E  4  The effect of the inhibiting PI3kinase, Akt and mTORC 1 and 2 on the secretion of STC-1 by BeWo cells. BeWo cells were 
cultured in 1% O2 in 100 µM 8 Bromo-cAMP in the presence and absence of (A) the PKA inhibitor H89 (10 µM), (B) the PI3kinase inhibitor Ly 
294002 (LY) at 1, 5 and 10 µM (n = 3) (C) Akt inhibitor IV (2.5 µM) or (D) either the mTORC1 inhibitor rapamycin (RAP) or the mTORC1 and 2 
inhibitor KU 0063794 (KU). (E) 10 µM (n = 5) and 100 µM (n = 3) GSK650394 in 1% O2 or, (F) 1 µM Kenpaullone. After 48 h, the medium was 
removed and the STC-1 secreted measured by ELISA. Total cellular protein was determined by Bradford assay. The results are expressed as pg of 
STC-1/mg of protein. All data were expressed as mean + SEM. The level of significance was determined using a one-way ANOVA and a Sidak's 
multiple comparisons test, or an unpaired t-test *P < .5, **P < .01 and ***P < .001
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Studies in HUVEC and HeLa cells37 support the view 
that both HIF-1α and HIF-2α are regulated by mTOR sig-
naling. mTOR is associated with two mTOR complexes, 
(mTORC) 1 and 2, which act both downstream and up-
stream of Akt, respectively.38 Although HIF-1α expres-
sion seems to be regulated by mTORC-1 and -2, HIF-2α 
expression was primarily dependent on mTORC2.39,40 To 
assess the role of mTOR in trophoblast secretion of STC-1 
by 8Br-cAMP and 1% O2, we used rapamycin which targets 
mTORC1 and KU-0063794 which inhibits both mTORC-1 
and 2. KU-0063794, but not rapamycin, significantly in-
hibited STC-1 secretion by trophoblasts indicating that 
mTORC-2 is primarily involved in the regulation of STC-1 
secretion by BeWo cells.
Activation of mTORC2 in turn activates a number of 
proteins including Akt, and SGK-1. In the present study 
as with Akt, inhibition of SGK-1 led to a dose-dependent 
inhibition of STC-1 secretion. One of the targets of SGK-1 
is NDRG-1. NDRG-1 expression has also been shown to be 
regulated by hypoxia through the activation of HIF-1α.41 
We, therefore, examined the role of NDRG-1 on the se-
cretion of STC-1 by BeWo cells. Stimulation of BeWo 
cells lead to a significant increase in the phosphorylation 
of NDRG-1 at both 1% and 21% O2 and this was not af-
fected following inhibition of HIF-2α with PT2385. Direct 
activation of NDRG-1 by Dp44tm had no effect on STC-1 
secretion. This suggests that although activated under these 
conditions, NDRG-1 played no role in the secretion of 
STC-1 by BeWo cells. Both Akt and SGK-1 are members 
of the same AGC subfamily of protein kinases and have 
similar substrate specificities. Both Akt and SGK-1 phos-
phorylate and inactivate GSK-3β. Inhibition of GSK-3β 
using kenpaullone resulted in an increase in STC-1 secre-
tion further supporting a role for GSK-3β as a negative 
regulator. When active, GSK-3β is known to phosphory-
late HIF-1α targeting it for proteasomal degradation.42-44 
Whether GSK-3β has the same effect on HIF-2α has yet to 
be determined.
In conclusion, we have shown that STC-1 is expressed by 
syncytial cytotrophoblasts, and is secreted in greater amounts 
by first trimester chorionic villous tissue under conditions of 
low oxygen. We have demonstrated that in low oxygen, the se-
cretion of STC-1 by a human trophoblast cell line is increased 
by elevated intracellular cAMP. We have further shown that this 
response is mediated through the activation of the PI3-Kinase/
Akt/SGK-1 pathway primarily through activation of mTORC-2 
and involves the transcription factor HIF-2α. While some cau-
tion should always be taken when extrapolating in vitro results 
using cell lines to the in vivo situation, we were also able to 
demonstrate a similar result using chorionic villous explants 
which more closely model the in vivo situation. This, together 
with the localization of STC-1 to the trophoblastic layers of the 
chorionic villi, points to a potentially important role for STC-1 
in the maintenance of a normal healthy pregnancy.
Although the role of STC-1 in pregnancy is unclear it has 
positive effects on cardiac function including the inhibition 
of hypoxia-induced cardiomyocyte apoptosis and attenuation 
of ischemic cardiac injury. A therapeutic role in heart failure 
has also been proposed. Given increasing evidence that the 
maternal cardiovascular system is fundamentally involved 
in the etiology of preeclampsia,45 we postulate that STC-1 
might protect the maternal cardiovascular system from stress 
in normal pregnancy however its role in preeclampsia/FGR is 
less clear and warrants further study.
F I G U R E  5  Summary of the pathway intermediates involved in the secretion STC-1 by BeWo cells. Solid arrows indicate demonstrated 
connections, dashed arrows are connections based on the literature
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